Epsilon M&A Deal Report - Branded generic business of Industrial Farmaceutica Cantabria
Transaction Multiples for the Valuation of Private Companies
Wanbury / Branded generic business of Industrial Farmaceutica Cantabria
No EMAT :
17047
Announced Date :
17/10/2006
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Wanbury
Target :
Branded generic business of Industrial Farmaceutica Cantabria
Country :
Spain
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Manufactures generic drugs > Cantabria Pharma is the branded generic drugs business of Industria Farmaceutica Cantabria
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/09/2006 | OPG Group | Dia Real | Germany | *** | 17046 |
| 21/08/2006 | Capio | Deutsche Klinik | Germany | ** | 17044 |
Source: Epsilon Research / EMAT
